中国临床新医学
中國臨床新醫學
중국림상신의학
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
2014年
12期
1113-1117
,共5页
陈杏春%农生洲%赵丽%梁亮
陳杏春%農生洲%趙麗%樑亮
진행춘%농생주%조려%량량
脑膜败血伊丽莎白菌%多药耐药%超广谱β-内酰胺酶%金属β-内酰胺酶
腦膜敗血伊麗莎白菌%多藥耐藥%超廣譜β-內酰胺酶%金屬β-內酰胺酶
뇌막패혈이려사백균%다약내약%초엄보β-내선알매%금속β-내선알매
Elizabethkingia meningoseptica(EME)%Multi-drug resistance%Extended spectrum β-lacta-mase(ESBLs)%Metallo β-laetamase(MBL)
目的:了解临床分离脑膜败血伊丽莎白菌( EME)的耐药率并进行耐药表型分析。方法采用微量肉汤稀释法( MIC)和KB法检测30株EME对22种抗菌药物的耐药率,用纸片法、改良三维试验法进行超广谱β-内酰胺酶(ESBLs)、头孢菌素酶(Ampc)和金属β-内酰胺酶(MBL)的表型确证试验。结果30株EME对所有β-内酰胺类药物的耐药率达70%以上,而对环丙沙星和左氧氟沙星及含酶抑制剂的哌拉西林/他唑巴坦和头孢哌酮/舒巴坦有较好的敏感性。对万古霉素和利福平耐药率分别为23.3%和16.7%。所有菌株均检出ESBLs而未检出Ampc,18株(60.0%)细菌检出产MBL。结论 EME是多药耐药的细菌,产ES-BLs和MBL,其中ESBLs对β-内酰胺类药物的耐药起主要作用。临床常用于治疗革兰阴性杆菌的亚胺培南和美罗培南对EME效果差,而用于治疗革兰阳性球菌的万古霉素和利福平对该菌有治疗活性,复方新诺明、米诺环素、含酶抑制剂类、氟喹喏酮类药物是治疗的首选。
目的:瞭解臨床分離腦膜敗血伊麗莎白菌( EME)的耐藥率併進行耐藥錶型分析。方法採用微量肉湯稀釋法( MIC)和KB法檢測30株EME對22種抗菌藥物的耐藥率,用紙片法、改良三維試驗法進行超廣譜β-內酰胺酶(ESBLs)、頭孢菌素酶(Ampc)和金屬β-內酰胺酶(MBL)的錶型確證試驗。結果30株EME對所有β-內酰胺類藥物的耐藥率達70%以上,而對環丙沙星和左氧氟沙星及含酶抑製劑的哌拉西林/他唑巴坦和頭孢哌酮/舒巴坦有較好的敏感性。對萬古黴素和利福平耐藥率分彆為23.3%和16.7%。所有菌株均檢齣ESBLs而未檢齣Ampc,18株(60.0%)細菌檢齣產MBL。結論 EME是多藥耐藥的細菌,產ES-BLs和MBL,其中ESBLs對β-內酰胺類藥物的耐藥起主要作用。臨床常用于治療革蘭陰性桿菌的亞胺培南和美囉培南對EME效果差,而用于治療革蘭暘性毬菌的萬古黴素和利福平對該菌有治療活性,複方新諾明、米諾環素、含酶抑製劑類、氟喹喏酮類藥物是治療的首選。
목적:료해림상분리뇌막패혈이려사백균( EME)적내약솔병진행내약표형분석。방법채용미량육탕희석법( MIC)화KB법검측30주EME대22충항균약물적내약솔,용지편법、개량삼유시험법진행초엄보β-내선알매(ESBLs)、두포균소매(Ampc)화금속β-내선알매(MBL)적표형학증시험。결과30주EME대소유β-내선알류약물적내약솔체70%이상,이대배병사성화좌양불사성급함매억제제적고랍서림/타서파탄화두포고동/서파탄유교호적민감성。대만고매소화리복평내약솔분별위23.3%화16.7%。소유균주균검출ESBLs이미검출Ampc,18주(60.0%)세균검출산MBL。결론 EME시다약내약적세균,산ES-BLs화MBL,기중ESBLs대β-내선알류약물적내약기주요작용。림상상용우치료혁란음성간균적아알배남화미라배남대EME효과차,이용우치료혁란양성구균적만고매소화리복평대해균유치료활성,복방신낙명、미낙배소、함매억제제류、불규야동류약물시치료적수선。
Objective To investigate drug resistance and resistance phenotypes of Elizabethkingia meningo-septica(EME).Methods The drug resistance rates of 30 strains to 22 antibiotics were detected by MIC and disk dilu-tion method.Phenotypes of extended spectrum β-lactamase(ESBLs), Ampc and metallo β-lactamase(MBL) were de-tected by disk diffusion and modified three dimension test .Results The drug resistance rates of 30 strains toβ-lactam grop drugs were above 70%, all strains were more susceptible to trimethoprim-sulfa(SXT), ciprofloxacin, levofloxacin, piperacillin/tazobactam, cefoperazone/sulbactam.The drug resistance rates to vancomycin and rifampi were 23.3%and 16.7%respectively.All the isolates were detected to have ESBLs but no Ampc , 18 strains(60.0%) had MBL.Con-clusion EME was multi-drug resistance , it can produce ESBLs and MBL .While ESBLs was most responsible for the resistance to β-lactam group drugs .EME was more resistance to imipenem and meropenem which were used to cure most of the gram negative bacilli , but more susceptible to vancomycin and rifampin which were used to cure most of the gram positive coccus.SXT, minocycline,β-lactamase inhibitor and quinolones drugs may be the best choice for its in-fection.